Profound Medical Corp.
NASDAQ Capital MarketTotal Valuation
Profound Medical Corp. carries a market capitalization of 250.37M, placing it among publicly traded companies globally. Its enterprise value stands at 313.95M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 250.37M |
| Enterprise Value | 313.95M |
Share Statistics
Profound Medical Corp. currently has 36.53M shares outstanding.
| Shares Outstanding | 36.53M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 16.50, and the price-to-book ratio stands at 6.92.
| PE Ratio | N/A |
| PS Ratio | 16.50 |
| PB Ratio | 6.92 |
| P/TBV Ratio | 6.94 |
| P/FCF Ratio | -8.73 |
| P/OCF Ratio | -8.73 |
Enterprise Valuation
| EV / Sales | 16.45 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
Profound Medical Corp. maintains a current ratio of 6.46, meaning it holds 6.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 6.46 |
| Quick Ratio | 5.25 |
| Debt / Equity | 14.82 |
| Debt / EBITDA | -0.21 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | -73.53 |
| Return on Assets (ROA) | -58.45 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.57 |
Taxes
| Income Tax | 227,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
Profound Medical Corp.'s stock has gained approximately 67.6399% over the past 52 weeks. The 50-day moving average sits at 7.07, while the 200-day moving average is 6.91.
| Beta (5Y) | N/A |
| 52-Week Price Change | 67.6399% |
| 50-Day Moving Average | 7.07 |
| 200-Day Moving Average | 6.91 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Profound Medical Corp. generated 19.09M in revenue and converted that into -32.74M in net income, yielding earnings per share of -0.98. EBITDA reached -34.88M, while operating income came in at -35.37M.
| Revenue | 19.09M |
| Gross Profit | 13.70M |
| Operating Income | -35.37M |
| Pretax Income | -32.52M |
| Net Income | -32.74M |
| EBITDA | -34.88M |
| EBIT | -35.37M |
| Earnings Per Share (EPS) | -0.98 |
Balance Sheet
Profound Medical Corp. holds 38.27M in cash and equivalents against 7.38M in total debt, resulting in a net debt position of -33.76M. Total book value stands at 49.81M, with working capital of 49.75M providing operational flexibility.
| Cash & Cash Equivalents | 38.27M |
| Total Debt | 7.38M |
| Net Debt | -33.76M |
| Equity (Book Value) | 49.81M |
| Book Value Per Share | 1.36 |
| Working Capital | 49.75M |
Cash Flow
Profound Medical Corp. produced -36.10M in operating cash flow over the past twelve months.
| Operating Cash Flow | -36.10M |
| Capital Expenditures | N/A |
| Free Cash Flow | -36.10M |
| FCF Per Share | -1.08 |
Margins
Profound Medical Corp. operates with a gross margin of 71.79, reflecting its pricing power and cost economics. The operating margin of -185.31 and net profit margin of -171.57 provide insight into operational efficiency.
| Gross Margin | 71.79 |
| Operating Margin | -185.31 |
| Pretax Margin | -170.38 |
| Profit Margin | -171.57 |
| EBITDA Margin | -182.74 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -12.01 |
| FCF Yield | -11.46 |
Stock Splits
Profound Medical Corp.'s most recent stock split took place on October 16, 2019 with a 10:1 split ratio.
| Last Split Date | 10/16/2019 |
| Split Ratio | 10:1 |
Scores
Profound Medical Corp. posts an Altman Z-Score of 9.00, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 9.00 |